Skip to main content
Dimitri Azar, MD, Ophthalmology, Chicago, IL

DimitriT.AzarMD

Ophthalmology Chicago, IL

Professor of Ophthalmology, University of Illinois College of Medicine

Dr. Azar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Azar's full profile

Already have an account?

  • Office

    1855 W Taylor St
    Chicago, IL 60612
    Phone+1 617-640-9909

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1987 - 1990
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 1983

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2023 - 2026
  • CA State Medical License
    CA State Medical License 2022 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2026
  • MT State Medical License
    MT State Medical License 2023 - 2026
  • ND State Medical License
    ND State Medical License 2023 - 2026
  • American Board of Ophthalmology Ophthalmology
  • Join now to see all

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2005-2014
  • Chicago Magazine: Top Doctors Castle Connolly, 2008, 2010, 2012, 2014
  • Boston Herald Castle Connolly, 2005
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Verily Establishes a Joint Venture with Santen to Develop Unique Ophthalmic Devices
    Verily Establishes a Joint Venture with Santen to Develop Unique Ophthalmic DevicesFebruary 5th, 2020
  • Verily Launches Joint Venture to Develop & Commercialize Ophthalmic Devices
    Verily Launches Joint Venture to Develop & Commercialize Ophthalmic DevicesFebruary 4th, 2020
  • Artificial Intelligence Gains More Acceptance in Ophthalmology
    Artificial Intelligence Gains More Acceptance in OphthalmologyApril 23rd, 2019

Grant Support

  • Metalloproteinase Expression In Corneal WoundsNational Eye Institute2006–2012
  • Uic K12 Independent Clinical Vision Scientist Development ProgramNational Eye Institute2011
  • P30 - Core Grant For Vision ResearchNational Eye Institute2009–2011
  • P-30-Core Grant For Vision ResearchNational Eye Institute2008
  • Core Grant For Vision ResearchNational Eye Institute2007
  • Metalloproteinase Expression In Corneal WoundsNational Eye Institute1999–2005
  • Core - AdministrativeNational Eye Institute2003
  • Metalloproteinase Expression In Corneal WoundsNational Eye Institute1996–1998
  • Metalloproteinase Expression In Corneal WoundsNational Eye Institute1994–1996
  • Corneal Epithelial Adhesion &Wound Healing In DiabetesFogarty International Center1986–1987